BEAM
Beam Therapeutics·NASDAQ
--
--(--)
--
--(--)
3.97 / 10
Netural
Analyst consensus splits: 33% Strong Buy, 33% Buy, 33% Neutral. Sentiment is neutral, yet fund‑flow score is 7.94/10 (good). Extra‑large investors show net inflow, while overall trend remains negative. Caution advised.
Fund Flow Rating
Analyst RatingStrong Buy
Wall Street Opinions
Strong Buy
Strong Buy
33%
Buy
33%
Hold
0%
Sell
0%
Strong Sell
0%
Date2026-02-25
InstitutionWedbush
Times predicted1
Historical Win Rate0.0%
What is the market sentiment for BEAM?
- BEAM holds a Bearish analyst rating, with 33% of experts assigning a Strong Buy grade. Factoring in net Outflows from order flow data, the comprehensive Sentiment Score stands at 3.97/10 (Netural).
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
